Bodo Grimbacher1, Klaus Warnatz, Hans-Hartmut Peter. 1. Department of Rheumatology and Clinical Immunology, Medical Center of the University of Freiburg, Freiburg, Germany. grimbacher@medizin.ukl.uni-freiburg.de
Abstract
RECENT FINDINGS: The ICOS is one of the many costimulatory molecules of T cells. Recently, the authors discovered that the homozygous loss of the ICOS in humans presents as common variable immunodeficiency, the most prevalent treated primary immunodeficiency in man. Therefore, the ICOS is after CD40 and CD40-ligand deficiency the third costimulatory molecule for which a human disease has been described. PURPOSE OF REVIEW: The description of ICOS deficiency made it necessary to review the vast amount of knowledge from experimental models in the light of a new clinical immunodeficiency phenotype. To this end, after introducing the ICOS and its ligand and comparing the murine and human 'knockout', the role of the ICOS in parasitic and viral infections, asthma, autoimmunity, transplantation immunology, and tumor surveillance will be discussed. SUMMARY: The focus of this review is the interaction between the ICOS and its ligand, which is essential for T cell dependent B cell responses.
RECENT FINDINGS: The ICOS is one of the many costimulatory molecules of T cells. Recently, the authors discovered that the homozygous loss of the ICOS in humans presents as common variable immunodeficiency, the most prevalent treated primary immunodeficiency in man. Therefore, the ICOS is after CD40 and CD40-ligand deficiency the third costimulatory molecule for which a human disease has been described. PURPOSE OF REVIEW: The description of ICOS deficiency made it necessary to review the vast amount of knowledge from experimental models in the light of a new clinical immunodeficiency phenotype. To this end, after introducing the ICOS and its ligand and comparing the murine and human 'knockout', the role of the ICOS in parasitic and viral infections, asthma, autoimmunity, transplantation immunology, and tumor surveillance will be discussed. SUMMARY: The focus of this review is the interaction between the ICOS and its ligand, which is essential for T cell dependent B cell responses.
Authors: P'ng Loke; Xingxing Zang; Lisa Hsuan; Rebecca Waitz; Richard M Locksley; Judith E Allen; James P Allison Journal: Proc Natl Acad Sci U S A Date: 2005-07-01 Impact factor: 11.205
Authors: Hong-Ying Wang; Vivek Gopalan; Ivona Aksentijevich; Meredith Yeager; Chi Adrian Ma; Yasmin Ali Mohamoud; Mariam Quinones; Casey Matthews; Joseph Boland; Julie E Niemela; Troy R Torgerson; Silvia Giliani; Gulbu Uzel; Jordan S Orange; Ralph Shapiro; Luigi Notarangelo; Hans D Ochs; Thomas Fleisher; Daniel Kastner; Stephen J Chanock; Ashish Jain Journal: Hum Mutat Date: 2010-09 Impact factor: 4.878
Authors: Cindy S Ma; Stefania Pittaluga; Danielle T Avery; Nathan J Hare; Irina Maric; Amy D Klion; Kim E Nichols; Stuart G Tangye Journal: J Clin Invest Date: 2006-01-19 Impact factor: 14.808
Authors: Cindy S Ma; Nathan J Hare; Kim E Nichols; Loic Dupré; Grazia Andolfi; Maria-Grazia Roncarolo; Stephen Adelstein; Philip D Hodgkin; Stuart G Tangye Journal: J Clin Invest Date: 2005-03-03 Impact factor: 14.808